This session provides a focused overview of novel psychoactive substances encountered in addiction medicine, including synthetic stimulants, cannabinoids, hallucinogens, opioids, and other emerging compounds in the illicit drug supply. Aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas, the session examines patterns of use, evolving drug markets, clinical effects, toxicology challenges, and evidence-based approaches to the evaluation and management of patients exposed to novel psychoactive substances.
What This Covers
• Categories of novel psychoactive substances, including synthetic stimulants, cannabinoids, hallucinogens, and opioids
• Patterns of use and evolving drug markets
• Variability in substance composition, including adulterants and unregulated compounds
• Challenges in detection and interpretation of toxicology results
• Clinical presentations of intoxication, including sympathomimetic and serotonergic toxicity
• Recognition and management of intoxication syndromes using supportive care strategies
• Practical approaches to evaluating and managing patients exposed to novel psychoactive substances
How This Resource Is Used
This session is designed for on-demand learning, focused content review, and board preparation. It may be used to reinforce foundational addiction medicine concepts, supplement fellowship training, or support preparation for addiction medicine certification examinations. Learners can engage with specific topic areas independently or complete the full session as part of a structured study plan.